A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia
Eligible for screening study DCP 001
Site staff should complete the information required on Site Activation Form (Click Here) and submit it to the Alliance Pharmaceutical Affairs Manager at pharmaffairs@alliancenctn.org, along with a copy of the site’s pharmacy or physician license.
“Please rate your appetite over the past 24 hours” on the Numerical Rating Scale is to be asked ≤5 days prior to registration.